SKI Market

A+| A| A-|

Indian Indices

Sensex

71,947.55 -1,635.67
( -2.22%)

Global Indices

Nasdaq

45,242.12 54.47
(0.12%)

Dow Jones

6,365.58 -24.27
(-0.38%)

Hang Seng

51,264.29 -621.56
(-1.20%)

Nikkei 225

10,176.45 48.49
(0.48%)

Forex

USD-INR

94.53 0.44
(0.47%)

EUR-INR

108.77 0.13
(0.12%)

GBP-INR

125.32 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Onyx Biotec Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

93585

INE0WVU01018

30.6759797

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ONYX

14.59

61.65

EPS(TTM)

Face Value()

Div & Yield %

2.33

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	358.30	358.85	346.32	353.83	301.49	310.51
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	358.30	358.85	346.32	353.83	301.49	310.51
Other Income	5.41	6.40	0.82	2.44	1.70	0.24
Stock Adjustments	29.30	22.56	16.95	-2.49	0.47	15.98
Total Income	393.01	387.81	364.09	353.78	303.66	326.73
EXPENDITURE :
Raw Materials	285.40	286.03	266.37	260.93	226.23	222.67
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	6.74
Employee Cost	15.74	13.92	14.58	14.59	12.55	20.02
Other Manufacturing Expenses	37.44	34.62	41.09	34.72	33.70	6.55
Selling & Administrative Expenses	14.71	13.82	12.76	11.84	6.78	8.68
Miscellaneous Expenses	1.68	0.68	1.54	8.91	8.07	45.84
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	354.97	349.07	336.34	330.99	287.33	310.50
Operating Profit	38.04	38.74	27.74	22.78	16.32	16.23
Interest	11.75	11.97	11.87	10.54	7.65	8.26
Gross Profit	26.29	26.77	15.87	12.24	8.67	7.97
Depreciation	4.25	3.35	3.59	4.17	2.75	2.73
Profit Before Tax	22.04	23.42	12.28	8.07	5.92	5.24
Tax	6.00	6.31	3.03	1.89	1.23	1.48
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	1.21	-0.13	0.43	0.24	0.47	-0.27
Reported Net Profit	14.83	17.24	8.82	5.94	4.22	4.03
Extraordinary Items	0.38	2.69	0.00	-0.01	0.06	0.03
Adjusted Net Profit	14.45	14.55	8.82	5.95	4.16	4.00
Adjustment below Net Profit	0.00	-27.32	0.00	0.00	0.00	-1.74
P & L Balance brought forward	29.11	39.18	30.36	27.70	23.48	21.18
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	43.94	29.11	39.18	33.64	27.70	23.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.82	2.58	76.16	51.87	36.87	35.04
Earnings Per Share(Adj)-Unit Curr	1.82	2.58	76.16	51.87	36.87	35.04
Book Value-Unit Curr	30.49	18.53	634.02	580.35	528.48	489.83
Book Value(Adj)-Unit Curr	30.49	18.53	634.02	580.35	528.48	489.83

71,947.55 -1,635.67 ( -2.22%)

45,242.12 54.47 (0.12%)

6,365.58 -24.27 (-0.38%)

51,264.29 -621.56 (-1.20%)

10,176.45 48.49 (0.48%)

94.53 0.44 (0.47%)

108.77 0.13 (0.12%)

125.32 -0.25 (-0.20%)

0.59 0.00 (-0.02%)